PET CT Scan in Mumbai: What Cancer Patients Need to Know Before Booking
Cancer diagnosis and treatment have changed dramatically over the last decade. Where oncologists once relied on clinical examination and basic imaging to understand the extent of disease, they now have access to far more powerful tools that reveal what is happening inside the body at a cellular and molecular level. Among these tools, the PET CT scan in Mumbai has become one of the most requested and clinically significant imaging studies in modern oncology. Yet many patients arrive for their scan without fully understanding what it involves, why their doctor has recommended it, and what to expect before, during, and after the procedure.
If you or someone you care for has been referred for this study, this guide will give you the clarity you need before you book your appointment.
What Is a PET CT Scan and Why Do Oncologists Rely on It
PET stands for Positron Emission Tomography, and CT stands for Computed Tomography. When combined into a single study, the PET CT scan delivers two types of information simultaneously: metabolic activity data from the PET component and precise anatomical detail from the CT component. This combination is what makes it so powerful in cancer care.
The PET portion of the scan works by detecting the activity of a radioactive tracer, most commonly Fluorodeoxyglucose or FDG, that is injected into the patient's bloodstream before the scan begins. Cancer cells are known to consume glucose at a significantly higher rate than normal cells because of their rapid and uncontrolled growth. The FDG tracer accumulates preferentially in these hypermetabolic cells and emits signals that the PET scanner detects, producing a map of areas with abnormally high metabolic activity across the entire body.
The CT scan then layers anatomical precision on top of this functional data, allowing the nuclear medicine physician and radiologist to say not just that there is suspicious metabolic activity but exactly where in the body it is located, how large the lesion is, and what surrounding structures are involved.
This dual capability makes whole-body PET CT imaging the preferred tool for cancer staging, restaging after treatment, monitoring response to chemotherapy or immunotherapy, and detecting recurrence. It is particularly well suited for lymphoma, lung cancer, colorectal cancer, oesophageal cancer, cervical cancer, and head and neck malignancies, among others.
Beyond FDG, newer and more targeted radiotracers are now available for specific cancer types. PSMA-PET uses a prostate specific membrane antigen tracer to detect prostate cancer with remarkable sensitivity, even at very low PSA levels. DOTATOC-PET or DOTA-PET targets somatostatin receptors found on neuroendocrine tumours. FAPI-PET, one of the newest tracers in clinical use, targets fibroblast activation protein and is showing strong results in cancer types where FDG-PET has limitations.
What Cancer Patients Must Know Before Booking Their Scan
One of the most important things a patient can do before booking a nuclear medicine scan is understand the preparation requirements, because inadequate preparation can directly affect the quality and accuracy of the study.
For FDG-PET CT, strict fasting for six hours before the scan is mandatory. Only plain water is permitted during the fasting period. This is because elevated blood glucose levels can compete with the FDG tracer and reduce its uptake in cancer cells, leading to a scan that may underrepresent the extent of disease. Diabetic patients require special preparation protocols and should inform the centre well in advance.
Patients who are admitted to hospital and receiving IV fluids must ensure that glucose-containing salines such as DNS or Ringer's Lactate are stopped at least 12 hours before the PET CT appointment. This is a frequently overlooked preparation point that can result in a cancelled or suboptimal scan.
A serum creatinine report is compulsory before the procedure, as CT contrast agents used in the anatomical component of the scan are processed through the kidneys. Patients with impaired renal function may require dose adjustments or alternative protocols.
The entire scan session takes approximately 3 to 4 hours from the time of tracer injection to completion of image acquisition. Patients are required to rest quietly in a designated waiting area after the injection while the tracer distributes through the body. Physical activity during this uptake period can cause FDG to concentrate in muscles rather than tumour tissue, again affecting scan quality.
One relative must accompany the patient throughout the appointment. Patients should not wear any jewellery and should bring all previous imaging reports, films, and CDs to the appointment so that the reporting radiologist can correlate findings with prior studies.
For PSMA-PET, the fasting requirement is shorter at 2 to 3 hours, and the procedure is otherwise similar in structure. The advantage of PSMA-PET over a standard bone scan for prostate cancer staging is now well established in international oncology guidelines, and its availability at select centres in Mumbai is making a significant difference to treatment planning for prostate cancer patients across western India.
Choosing the Right Centre for Your PET CT Scan in Mumbai
Not all PET CT centres in Mumbai offer the same range of tracers, the same quality of equipment, or the same level of radiologist expertise in reporting nuclear medicine studies. When choosing a centre, patients and their oncologists should look for a facility that uses a high-quality PET scanner with proven sensitivity, has an in-house nuclear medicine physician who personally supervises tracer preparation and scan acquisition, and employs subspecialty-trained radiologists who report the findings themselves and communicate directly with the treating team.
The availability of newer tracers such as PSMA, FAPI, and DOTATOC at the same centre is also a significant advantage, as it avoids the need for patients to visit multiple facilities for different aspects of their oncology imaging workup. Same-day reporting for morning appointments is another practical benefit that reduces anxiety and avoids delays in treatment planning.
Conclusion
A nuclear medicine scan is one of the most informative tools available to your oncology team, and preparing well for it ensures the most accurate results possible. If your doctor has referred you for a PET CT scan in Mumbai, choosing a centre with the right technology, the right tracers, and expert specialist reporting is the most important decision you can make at this stage of your care.
Picture This, Dr. Jankharia's Imaging Centre at Kamala Mills, Lower Parel, offers whole-body PET CT imaging on the Siemens HD PET machine with an in-house Gallium generator for PSMA and DOTATOC tracers. Dr. Bhavin Jankharia and nuclear physician Dr. Nusrat Shaikh personally report every scan, with same-day results for morning appointments. Contact Picture This today to book your appointment or speak to our team about your imaging requirements.
Cancer diagnosis and treatment have changed dramatically over the last decade. Where oncologists once relied on clinical examination and basic imaging to understand the extent of disease, they now have access to far more powerful tools that reveal what is happening inside the body at a cellular and molecular level. Among these tools, the PET CT scan in Mumbai has become one of the most requested and clinically significant imaging studies in modern oncology. Yet many patients arrive for their scan without fully understanding what it involves, why their doctor has recommended it, and what to expect before, during, and after the procedure.
If you or someone you care for has been referred for this study, this guide will give you the clarity you need before you book your appointment.
What Is a PET CT Scan and Why Do Oncologists Rely on It
PET stands for Positron Emission Tomography, and CT stands for Computed Tomography. When combined into a single study, the PET CT scan delivers two types of information simultaneously: metabolic activity data from the PET component and precise anatomical detail from the CT component. This combination is what makes it so powerful in cancer care.
The PET portion of the scan works by detecting the activity of a radioactive tracer, most commonly Fluorodeoxyglucose or FDG, that is injected into the patient's bloodstream before the scan begins. Cancer cells are known to consume glucose at a significantly higher rate than normal cells because of their rapid and uncontrolled growth. The FDG tracer accumulates preferentially in these hypermetabolic cells and emits signals that the PET scanner detects, producing a map of areas with abnormally high metabolic activity across the entire body.
The CT scan then layers anatomical precision on top of this functional data, allowing the nuclear medicine physician and radiologist to say not just that there is suspicious metabolic activity but exactly where in the body it is located, how large the lesion is, and what surrounding structures are involved.
This dual capability makes whole-body PET CT imaging the preferred tool for cancer staging, restaging after treatment, monitoring response to chemotherapy or immunotherapy, and detecting recurrence. It is particularly well suited for lymphoma, lung cancer, colorectal cancer, oesophageal cancer, cervical cancer, and head and neck malignancies, among others.
Beyond FDG, newer and more targeted radiotracers are now available for specific cancer types. PSMA-PET uses a prostate specific membrane antigen tracer to detect prostate cancer with remarkable sensitivity, even at very low PSA levels. DOTATOC-PET or DOTA-PET targets somatostatin receptors found on neuroendocrine tumours. FAPI-PET, one of the newest tracers in clinical use, targets fibroblast activation protein and is showing strong results in cancer types where FDG-PET has limitations.
What Cancer Patients Must Know Before Booking Their Scan
One of the most important things a patient can do before booking a nuclear medicine scan is understand the preparation requirements, because inadequate preparation can directly affect the quality and accuracy of the study.
For FDG-PET CT, strict fasting for six hours before the scan is mandatory. Only plain water is permitted during the fasting period. This is because elevated blood glucose levels can compete with the FDG tracer and reduce its uptake in cancer cells, leading to a scan that may underrepresent the extent of disease. Diabetic patients require special preparation protocols and should inform the centre well in advance.
Patients who are admitted to hospital and receiving IV fluids must ensure that glucose-containing salines such as DNS or Ringer's Lactate are stopped at least 12 hours before the PET CT appointment. This is a frequently overlooked preparation point that can result in a cancelled or suboptimal scan.
A serum creatinine report is compulsory before the procedure, as CT contrast agents used in the anatomical component of the scan are processed through the kidneys. Patients with impaired renal function may require dose adjustments or alternative protocols.
The entire scan session takes approximately 3 to 4 hours from the time of tracer injection to completion of image acquisition. Patients are required to rest quietly in a designated waiting area after the injection while the tracer distributes through the body. Physical activity during this uptake period can cause FDG to concentrate in muscles rather than tumour tissue, again affecting scan quality.
One relative must accompany the patient throughout the appointment. Patients should not wear any jewellery and should bring all previous imaging reports, films, and CDs to the appointment so that the reporting radiologist can correlate findings with prior studies.
For PSMA-PET, the fasting requirement is shorter at 2 to 3 hours, and the procedure is otherwise similar in structure. The advantage of PSMA-PET over a standard bone scan for prostate cancer staging is now well established in international oncology guidelines, and its availability at select centres in Mumbai is making a significant difference to treatment planning for prostate cancer patients across western India.
Choosing the Right Centre for Your PET CT Scan in Mumbai
Not all PET CT centres in Mumbai offer the same range of tracers, the same quality of equipment, or the same level of radiologist expertise in reporting nuclear medicine studies. When choosing a centre, patients and their oncologists should look for a facility that uses a high-quality PET scanner with proven sensitivity, has an in-house nuclear medicine physician who personally supervises tracer preparation and scan acquisition, and employs subspecialty-trained radiologists who report the findings themselves and communicate directly with the treating team.
The availability of newer tracers such as PSMA, FAPI, and DOTATOC at the same centre is also a significant advantage, as it avoids the need for patients to visit multiple facilities for different aspects of their oncology imaging workup. Same-day reporting for morning appointments is another practical benefit that reduces anxiety and avoids delays in treatment planning.
Conclusion
A nuclear medicine scan is one of the most informative tools available to your oncology team, and preparing well for it ensures the most accurate results possible. If your doctor has referred you for a PET CT scan in Mumbai, choosing a centre with the right technology, the right tracers, and expert specialist reporting is the most important decision you can make at this stage of your care.
Picture This, Dr. Jankharia's Imaging Centre at Kamala Mills, Lower Parel, offers whole-body PET CT imaging on the Siemens HD PET machine with an in-house Gallium generator for PSMA and DOTATOC tracers. Dr. Bhavin Jankharia and nuclear physician Dr. Nusrat Shaikh personally report every scan, with same-day results for morning appointments. Contact Picture This today to book your appointment or speak to our team about your imaging requirements.
Comments